Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs Intravenous Tranexamic Acid for Hemoptysis
NCT07845747Phase 4Enrolling by invitation
- Sponsor
- Dow University of Health Sciences
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in hemoptysis, sponsored by Dow University of Health Sciences. Started Sep 2026; status: enrolling by invitation.
02
Drugs
tranexamic acid
03
Conditions
hemoptysis
Beyond the preview
Go deeper on NCT07845747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845747.